Lnhc Drug Patent Portfolio

Lnhc owns 2 orange book drugs protected by 17 US patents Given below is the list of Lnhc's drug patents along with their expiration dates.

Drug Patent Number Drug Patent Title Drug Patent Expiry Status
US10322081 Topical antiviral compositions and methods of using the same 10 Jul, 2035
Active
US10736839 Topical antiviral compositions, delivery systems, and methods of using the same 10 Jul, 2035
Active
US11040006 Topical antiviral compositions, delivery systems, and methods of using the same 10 Jul, 2035
Active
US11723858 Topical antiviral compositions, delivery systems, and methods of using the same 10 Jul, 2035
Active
US10258564 Topical compositions and methods of using the same 22 Nov, 2034
Active
US11285098 Topical compositions and methods of using the same 28 Feb, 2034
Active
US9855211 Topical compositions and methods of using the same 27 Feb, 2034
Active
US10265334 Anhydrous compositions 03 Jul, 2032
Active
US9289442 Topical compositions 03 Jul, 2032
Active
US9526738 Topical gels and methods of using the same 03 Sep, 2031
Active
US10376538 Topical gels and methods of using the same 20 Aug, 2030
Active
US9737561 Topical gels and methods of using the same 20 Aug, 2030
Active
US8592434 Mucoadhesive buccal tablets for the treatment of orofacial herpes 16 Jun, 2030
Active
US8747896 Mucosal bioadhesive slow release carrier for delivering active principles 03 Jun, 2027
Active
US8791127 Mucosal bioadhesive slow release carrier for delivering active principles 23 Mar, 2027
Active
US8282967 Nitric oxide-releasing particles for nitric oxide therapeutics and biomedical applications 30 May, 2026
Active
US8956658 Nitric oxide-releasing particles for nitric oxide therapeutics and biomedical applications 30 May, 2026
Active


Given below is the list of recent legal activities going on the following drug patents of Lnhc.

Activity Date Patent Number
Patent litigations
Payment of Maintenance Fee, 8th Yr, Small Entity 27 Jun, 2024 US9526738
Payment of Maintenance Fee, 12th Yr, Small Entity 22 Mar, 2024 US8282967
Change in Power of Attorney (May Include Associate POA) 05 Mar, 2024 US9855211
Email Notification 05 Mar, 2024 US9855211
Initial letter Re: PTE Application to regulating agency 04 Mar, 2024 US9855211
Patent Term Extension Application under 35 USC 156 Filed 01 Mar, 2024 US9855211
Payment of Maintenance Fee, 4th Yr, Small Entity 12 Feb, 2024 US10736839
Electronic Review 15 Aug, 2023 US11723858
Recordation of Patent Grant Mailed 15 Aug, 2023 US11723858
Mail Patent eGrant Notification 15 Aug, 2023 US11723858
Patent Issue Date Used in PTA Calculation 15 Aug, 2023 US11723858
Recordation of Patent eGrant 15 Aug, 2023 US11723858
Email Notification 15 Aug, 2023 US11723858
Patent eGrant Notification 15 Aug, 2023 US11723858
Email Notification 27 Jul, 2023 US11723858


Lnhc's Family Patents

Lnhc drugs have patent protection in a total of 30 countries. It's US patent count contributes only to 15.4% of its total global patent coverage. 3 countries have all of their patents expired or invalidated which has opened up potential generic launch opportunities in these countries. Click below to unlock the full patent family tree.

Family Patents



Lnhc Drug List

Given below is the complete list of Lnhc's drugs and the patents protecting them.


1. Sitavig

Sitavig is protected by 3 patents, out of which none have expired yet. Check out its patent list below.

Drug Patent Number Drug Patent Title Drug Patent Expiry Status
US8592434 Mucoadhesive buccal tablets for the treatment of orofacial herpes 16 Jun, 2030
(5 years from now)
Active
US8747896 Mucosal bioadhesive slow release carrier for delivering active principles 03 Jun, 2027
(2 years from now)
Active
US8791127 Mucosal bioadhesive slow release carrier for delivering active principles 23 Mar, 2027
(2 years from now)
Active

Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Sitavig's drug page


2. Zelsuvmi

Zelsuvmi is protected by 14 patents, out of which none have expired yet. Check out its patent list below.

Drug Patent Number Drug Patent Title Drug Patent Expiry Status
US10322081 Topical antiviral compositions and methods of using the same 10 Jul, 2035
(10 years from now)
Active
US10736839 Topical antiviral compositions, delivery systems, and methods of using the same 10 Jul, 2035
(10 years from now)
Active
US11040006 Topical antiviral compositions, delivery systems, and methods of using the same 10 Jul, 2035
(10 years from now)
Active
US11723858 Topical antiviral compositions, delivery systems, and methods of using the same 10 Jul, 2035
(10 years from now)
Active
US10258564 Topical compositions and methods of using the same 22 Nov, 2034
(10 years from now)
Active
US11285098 Topical compositions and methods of using the same 28 Feb, 2034
(9 years from now)
Active
US9855211 Topical compositions and methods of using the same 27 Feb, 2034
(9 years from now)
Active
US10265334 Anhydrous compositions 03 Jul, 2032
(7 years from now)
Active
US9289442 Topical compositions 03 Jul, 2032
(7 years from now)
Active
US9526738 Topical gels and methods of using the same 03 Sep, 2031
(6 years from now)
Active
US10376538 Topical gels and methods of using the same 20 Aug, 2030
(5 years from now)
Active
US9737561 Topical gels and methods of using the same 20 Aug, 2030
(5 years from now)
Active
US8282967 Nitric oxide-releasing particles for nitric oxide therapeutics and biomedical applications 30 May, 2026
(1 year, 7 months from now)
Active
US8956658 Nitric oxide-releasing particles for nitric oxide therapeutics and biomedical applications 30 May, 2026
(1 year, 7 months from now)
Active

Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Zelsuvmi's drug page


Explore Our Curated Drug Screens

Drugs Generating Over $1 Billion in Annual Revenue
Explore the top-performing drugs that dominate the pharmaceutical industry
View List
NCE-1 Patent Expiry in the Next 1 Year
Identify opportunities as new chemical entity (NCE-1) patents approach expiry
View List
Recently Granted Patents in EP
Find the opportunity to file Oppositions
View List